These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16691010)

  • 1. Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.
    Moody TW; Nakagawa T; Kang Y; Jakowlew S; Chan D; Jensen RT
    J Mol Neurosci; 2006; 28(3):231-8. PubMed ID: 16691010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
    Moody TW; Leyton J; Garcia-Marin L; Jensen RT
    Eur J Pharmacol; 2003 Aug; 474(1):21-9. PubMed ID: 12909192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.
    Moody TW; Mantey SA; Moreno P; Nakamura T; Lacivita E; Leopoldo M; Jensen RT
    Peptides; 2015 Feb; 64():55-61. PubMed ID: 25554218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
    Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
    Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
    Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
    Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
    Jaeger M; Ghisleni EC; Fratini L; Brunetto AL; Gregianin LJ; Brunetto AT; Schwartsmann G; de Farias CB; Roesler R
    Childs Nerv Syst; 2016 Jan; 32(1):61-4. PubMed ID: 26590027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor.
    Langer DA; Kautzman D; Kane MA
    Lung Cancer; 2002 Jun; 36(3):235-42. PubMed ID: 12009231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
    Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
    Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
    Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
    Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines.
    Yang HK; Scott FM; Trepel JB; Battey JF; Johnson BE; Kelley MJ
    Lung Cancer; 1998 Sep; 21(3):165-75. PubMed ID: 9857994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
    Zhang Q; Bhola NE; Lui VW; Siwak DR; Thomas SM; Gubish CT; Siegfried JM; Mills GB; Shin D; Grandis JR
    Mol Cancer Ther; 2007 Apr; 6(4):1414-24. PubMed ID: 17431120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
    Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
    Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
    Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
    Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
    Hohla F; Schally AV; Kanashiro CA; Buchholz S; Baker B; Kannadka C; Moder A; Aigner E; Datz C; Halmos G
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18671-6. PubMed ID: 18003891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of BW2258U89, a GRP receptor antagonist.
    Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
    Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells.
    Leyton J; Garcia-Marin LJ; Tapia JA; Jensen RT; Moody TW
    Cancer Lett; 2001 Jan; 162(1):87-95. PubMed ID: 11121866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells.
    Moody TW; Jensen RT; Garcia L; Leyton J
    Eur J Pharmacol; 2000 Dec; 409(2):133-42. PubMed ID: 11104826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
    Kado-Fong H; Malfroy B
    J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
    Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
    Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.